Neural Therapeutics Inc. (NURL.CN)
Canadian Sec · CAD · Healthcare · Biotechnology
CA$0.01 (+0.00%) as of
Key statistics
- Market cap
- 1.69M
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.0000 – 0.0350
- Profit margin
- 0.00%
About Neural Therapeutics Inc.
Neural Therapeutics Inc., an ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada. The company utilizes psychoactive plants, such as San Pedro, a cactus containing mescaline, for the creation of plant-based traditional medicine. Its products target substance use disorders, including alcohol and opioid dependence. The company was formerly known as Psychedelic Science Corp. and changed its name to Neural Therapeutics Inc. in November 2021. Neural Therapeutics Inc. was founded in 2020 and is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Toronto, ON, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.